Clinical Trials Logo

Pain Measurement clinical trials

View clinical trials related to Pain Measurement.

Filter by:

NCT ID: NCT02025283 Completed - Pain Measurement Clinical Trials

Efficacy of Radiofrequency Nucleoplasty and Targeted Disc Decompression in Lumbar Radiculopathy

RFNaTDD
Start date: January 2010
Phase: N/A
Study type: Observational

The aim of this study is to compare early and long term efficacy of lumbar radiofrequency nucleoplasty and targeted disc decompression in patients with lumbar radiculopathy who failed previous conventional therapy. Medical records of 37 patients undergoing targeted disc decompression, 36 patients undergoing lumbar radiofrequency nucleoplasty were retrospectively examined.Visual Analogue Scale (VAS), Numerical Rating Scale (NRS), Functional Rating Index, Backache index, Oswestry Lumbar Back Pain Disability Index, Rolland-Morris Lumbar Back Pain Questionnaire scales were used before treatment and 1,6,12 months after the procedure. North American Spine Society Satisfaction Scale was used at 12th month after the procedure.

NCT ID: NCT01211600 Completed - Cesarean Section Clinical Trials

Cesarean Trial of Staples vs. Sutures

CROSS
Start date: June 2010
Phase: N/A
Study type: Interventional

To determine whether the rate of wound complications differs based on method of closure of skin incision (staples vs. suture) after cesarean delivery.

NCT ID: NCT01172782 Completed - Pain Measurement Clinical Trials

The Analgesic Effect of Intrathecal Hydromorphone Injection on Spinal Anesthesia

Start date: July 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the adequate dose of intrathecal hydromorphone injection for postoperative pain relief after knee arthroscopic surgery.

NCT ID: NCT01094574 Completed - Pain Measurement Clinical Trials

Evaluation of Propranolol's Effect on Pain and Inflammation.

Start date: January 2010
Phase: N/A
Study type: Interventional

Previous studies have shown that the beta-adrenergic system plays a role in processing pain and the expression of hyperalgesia. Recent studies have investigated the analgesic effects, and potential anti-hyperalgesic effects (using a model of opioid induced (OIH) hyperalgesia) of propranolol, a beta adrenergic antagonist. We plan to further investigate the analgesic effects, and the potential anti inflammatory effects, of propranolol and compare those effects to alfentanil, an opioid of known effect, and placebo

NCT ID: NCT00892411 Completed - Low Back Pain Clinical Trials

Prognostic Value of Measures of the Central Hypersensitivity in Patients With Acute Low Back Pain

Start date: February 2009
Phase: N/A
Study type: Observational

Background. Patients with chronic low back pain display hyperexcitability of the central nervous system (central hypersensitivity). Such hypersensitivity may occur in the acute phase and represent a risk factor for the development of chronic pain. Objective. To determine the prognostic value of central hypersensitivity for the development of chronic low back pain. Design. Prospective cohort study. Setting. Primary care. Patients. 140 individuals with acute low back pain and no history of chronic pain. Outcomes. Primary prognostic variable will be the pain tolerance threshold at the second toe (the pressure intensity at which a further increase in pressure is deemed intolerable). Exploratory secondary prognostic variables are measures of mechanisms related to central hypersensitivity: stimulus-specific hypersensitivity (pressure, electrical, heat and cold stimulation); tissue-specific hypersensitivity (skin vs. muscle stimulation); localized vs. widespread hypersensitivity; spinal cord modulation (electrophysiological measures of hypersensitivity and changes in receptive fields); modulation at brain level (descending modulation of nociceptive input and cortical plasticity). Clinical primary outcome will be the occurrence of chronic low back pain at follow-up. Main analysis. The investigators will use least square logistic regression models to determine the association of central hypersensitivity with prognosis. Relevance. An understanding of the prognostic value of central hypersensitivity may allow an early stratification for treatment of individuals at risk of developing chronic low back pain. Subgroups of patients may be selected for clinical trials on novel pharmacological approaches for the prevention and treatment of central hypersensitivity.

NCT ID: NCT00524927 Completed - Pain Measurement Clinical Trials

Safety and Efficacy of Methoxyflurane for Treatment of Incident Pain

Start date: September 2007
Phase: Phase 4
Study type: Interventional

This study aims to provide further supportive evidence that Methoxyflurane, a potent analgesic, administered using the Penthrox Inhaler is safe and efficacious in adult participants, specifically those who experience incident pain associated with a planned bone marrow biopsy.

NCT ID: NCT00420693 Completed - Newborn Clinical Trials

Interest of Using the Sevoflurane in the Prevention of Newborns Pain

Start date: August 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The objective of this randomized and controlled study is to compare the sedation with sevoflurane inhalation versus non-nutritive sucking and sucrose administration to facilitate peripheral inserted central catheter insertion in a pediatric and neonatal intensive care. Main measurements concern success or failure of insertion, duration of procedure, movements of the baby, tolerance of treatments evaluated by, mean arterial pressure, heart rate, respiratory frequency and oxygen saturation.